-
1
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
2
-
-
48649111052
-
Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects: response to Musso et al
-
Sookoian S, Burgueno AL, Castano G, Pirola CJ. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects: response to Musso et al Diabetes Care 2008;31:42-3.
-
(2008)
Diabetes Care
, vol.31
, pp. 42-43
-
-
Sookoian, S.1
Burgueno, A.L.2
Castano, G.3
Pirola, C.J.4
-
3
-
-
57649214103
-
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
-
Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009;48:1-26.
-
(2009)
Prog Lipid Res
, vol.48
, pp. 1-26
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
-
4
-
-
13744263104
-
Temporal pattern of de novo lipogenesis in the postprandial state in healthy men
-
Timlin MT, Parks EJ. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. Am J Clin Nutr 2005;81:35-42.
-
(2005)
Am J Clin Nutr
, vol.81
, pp. 35-42
-
-
Timlin, M.T.1
Parks, E.J.2
-
5
-
-
0037216466
-
Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets
-
Schwarz JM, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 2003;77:43-50.
-
(2003)
Am J Clin Nutr
, vol.77
, pp. 43-50
-
-
Schwarz, J.M.1
Linfoot, P.2
Dare, D.3
Aghajanian, K.4
-
6
-
-
0033791280
-
Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissues
-
Wilentz RE, Witters LA, Pizer ES. Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissues. Pediatr Dev Pathol 2000;3:525-31.
-
(2000)
Pediatr Dev Pathol
, vol.3
, pp. 525-531
-
-
Wilentz, R.E.1
Witters, L.A.2
Pizer, E.S.3
-
7
-
-
0033570119
-
Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus
-
Shimomura I, Bashmakow Y, Horton JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999;274:30028-32.
-
(1999)
J Biol Chem
, vol.274
, pp. 30028-30032
-
-
Shimomura, I.1
Bashmakow, Y.2
Horton, J.D.3
-
8
-
-
79955504163
-
PPAR{alpha} expression protects male mice from high fat-induced nonalcoholic fatty liver
-
Abdelmegeed MA, Yoo SH, Henderson LE, Gonzalez FJ, Woodcroft KJ, Song BJ. PPAR{alpha} expression protects male mice from high fat-induced nonalcoholic fatty liver. J Nutr 2011;141:603-10.
-
(2011)
J Nutr
, vol.141
, pp. 603-610
-
-
Abdelmegeed, M.A.1
Yoo, S.H.2
Henderson, L.E.3
Gonzalez, F.J.4
Woodcroft, K.J.5
Song, B.J.6
-
9
-
-
34447514029
-
Vitamin D deficiency
-
Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
-
(2007)
N Engl J Med
, vol.357
, pp. 266-281
-
-
Holick, M.F.1
-
10
-
-
78650876692
-
Vitamin D: evolutionary, physiological and health perspectives
-
Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2005;12:4-18.
-
(2005)
Curr Drug Targets
, vol.12
, pp. 4-18
-
-
Holick, M.F.1
-
11
-
-
31544436356
-
The influence of vitamin D on bone health across the life cycle
-
Holick MF. The influence of vitamin D on bone health across the life cycle. J Nutr 2005;135:2726S-7S.
-
(2005)
J Nutr
, vol.135
-
-
Holick, M.F.1
-
12
-
-
33751537194
-
Minireview: vitamin D receptor: new assignments for an already busy receptor
-
Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006;147:5542-8.
-
(2006)
Endocrinology
, vol.147
, pp. 5542-5548
-
-
Norman, A.W.1
-
13
-
-
33746583683
-
Vitamin D and cancer
-
Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. Vitamin D and cancer. Anticancer Res 2006;26:2515-24.
-
(2006)
Anticancer Res
, vol.26
, pp. 2515-2524
-
-
Spina, C.S.1
Tangpricha, V.2
Uskokovic, M.3
Adorinic, L.4
Maehr, H.5
Holick, M.F.6
-
14
-
-
60649109332
-
1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes
-
Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. 1Alpha, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009;45:190-7.
-
(2009)
Cytokine
, vol.45
, pp. 190-197
-
-
Almerighi, C.1
Sinistro, A.2
Cavazza, A.3
Ciaprini, C.4
Rocchi, G.5
Bergamini, A.6
-
15
-
-
77957252277
-
Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine
-
Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 2010;177:686-97.
-
(2010)
Am J Pathol
, vol.177
, pp. 686-697
-
-
Wu, S.1
Liao, A.P.2
Xia, Y.3
Li, Y.C.4
Li, J.D.5
Sartor, R.B.6
-
16
-
-
79960889033
-
Vitamin D intake and risk of cardiovascular disease in US men and women
-
Sun Q, Shi L, Rimm EB, Giovannucci EL, Hu FB, Manson JE et al. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr 2009;94:534-42.
-
(2009)
Am J Clin Nutr
, vol.94
, pp. 534-542
-
-
Sun, Q.1
Shi, L.2
Rimm, E.B.3
Giovannucci, E.L.4
Hu, F.B.5
Manson, J.E.6
-
17
-
-
74749104899
-
Vitamin D deficiency and type 2 diabetes
-
Ozfirat Z, Chowdhury TA. Vitamin D deficiency and type 2 diabetes. Postgrad Med J 2005;86:18-25.
-
(2005)
Postgrad Med J
, vol.86
, pp. 18-25
-
-
Ozfirat, Z.1
Chowdhury, T.A.2
-
18
-
-
79959470968
-
Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006
-
Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr 2008;94:225-33.
-
(2008)
Am J Clin Nutr
, vol.94
, pp. 225-233
-
-
Ganji, V.1
Zhang, X.2
Shaikh, N.3
Tangpricha, V.4
-
19
-
-
80054721883
-
Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons. A population-based study
-
Oosterwerff MM, Eekhoff EM, Heymans MW, Lips P, van Schoor NM. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons. A population-based study. Clin Endocrinol (Oxf) 2011;75:608-13.
-
(2011)
Clin Endocrinol (Oxf)
, vol.75
, pp. 608-613
-
-
Oosterwerff, M.M.1
Eekhoff, E.M.2
Heymans, M.W.3
Lips, P.4
van Schoor, N.M.5
-
20
-
-
63349086412
-
Hypovitaminosis D and ethnic differences in insulin resistance
-
Ji HF. Hypovitaminosis D and ethnic differences in insulin resistance. Hepatology 2009;49:791-801.
-
(2009)
Hepatology
, vol.49
, pp. 791-801
-
-
Ji, H.F.1
-
21
-
-
34547485376
-
Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease
-
Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007;17:517-24.
-
(2007)
Nutr Metab Cardiovasc Dis
, vol.17
, pp. 517-524
-
-
Targher, G.1
Bertolini, L.2
Scala, L.3
Cigolini, M.4
Zenari, L.5
Falezza, G.6
-
22
-
-
77952726719
-
Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease
-
Manco M, Ciampalini P, Nobili V. Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology 2010;51:2229-30.
-
(2010)
Hepatology
, vol.51
, pp. 2229-2230
-
-
Manco, M.1
Ciampalini, P.2
Nobili, V.3
-
23
-
-
79960445022
-
Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats
-
Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2011;55:415-25.
-
(2011)
J Hepatol
, vol.55
, pp. 415-425
-
-
Nakano, T.1
Cheng, Y.F.2
Lai, C.Y.3
Hsu, L.W.4
Chang, Y.C.5
Deng, J.Y.6
-
24
-
-
84856306983
-
Invalidation of the Vitamin D Nuclear Receptor promotes liver steatosis
-
Boston, MA: Hepatology
-
Zuñiga S, Firrincieli D, Lasnier E, Miquel JF, Housset C, Chignard N. Invalidation of the Vitamin D Nuclear Receptor promotes liver steatosis. In: Annual Meeting American Association for the Study of Liver Disease. Boston, MA: Hepatology; 2010: pp 1058A.
-
(2010)
Annual Meeting American Association for the Study of Liver Disease
, vol.A
, pp. 1058
-
-
Zuñiga, S.1
Firrincieli, D.2
Lasnier, E.3
Miquel, J.F.4
Housset, C.5
Chignard, N.6
-
25
-
-
80655127773
-
Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats
-
Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011 Dec;60:1728-37.
-
(2011)
Gut
, vol.60
, pp. 1728-1737
-
-
Abramovitch, S.1
Dahan-Bachar, L.2
Sharvit, E.3
Weisman, Y.4
Ben Tov, A.5
Brazowski, E.6
-
26
-
-
45949104817
-
1,25-Dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-1
-
Taher YA, van Esch BCAM, Hofman GA, Henricks PAJ, van Oosterhout AJM. 1, 25-Dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-1. J Immunol 2008;180:5211-21.
-
(2008)
J Immunol
, vol.180
, pp. 5211-5221
-
-
Taher, Y.A.1
van Esch, B.C.A.M.2
Hofman, G.A.3
Henricks, P.A.J.4
van Oosterhout, A.J.M.5
-
27
-
-
33646385595
-
Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells
-
Kong J, Li YC. Molecular mechanism of 1, 25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006;290:E916-24.
-
(2006)
Am J Physiol Endocrinol Metab
, vol.290
-
-
Kong, J.1
Li, Y.C.2
-
28
-
-
79954479073
-
The vitamin D receptor agonist doxercalciferol modulates dietary fat induced renal disease and renal lipid metabolism
-
Wang XX, Jiang T, Shen Y, Santamaria H, Solis N, Arbeeny C et al. The vitamin D receptor agonist doxercalciferol modulates dietary fat induced renal disease and renal lipid metabolism. Am J Physiol Renal Physiol 2011;300:F801-10.
-
(2011)
Am J Physiol Renal Physiol
, vol.300
-
-
Wang, X.X.1
Jiang, T.S.Y.2
Santamaria, H.3
Solis, N.4
Arbeeny, C.5
-
29
-
-
65549137566
-
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers
-
Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009;89:1321-7.
-
(2009)
Am J Clin Nutr
, vol.89
, pp. 1321-1327
-
-
Zittermann, A.1
Frisch, S.2
Berthold, H.K.3
Gotting, C.4
Kuhn, J.5
Kleesiek, K.6
-
30
-
-
77952863834
-
Genetic control of de novo lipogenesis: role in diet-induced obesity
-
Maggie SS, James MN. Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol 2010;45:199-214.
-
(2010)
Crit Rev Biochem Mol Biol
, vol.45
, pp. 199-214
-
-
Maggie, S.S.1
James, M.N.2
-
31
-
-
0034693259
-
Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action
-
Osborne TF. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem 2000;275:32379-82.
-
(2000)
J Biol Chem
, vol.275
, pp. 32379-32382
-
-
Osborne, T.F.1
-
32
-
-
34548392209
-
Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)
-
Ahmed MH, Byrne CD. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov Today 2007;12:740-7.
-
(2007)
Drug Discov Today
, vol.12
, pp. 740-747
-
-
Ahmed, M.H.1
Byrne, C.D.2
-
33
-
-
0036251153
-
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
-
Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002;109:1125-31.
-
(2002)
J Clin Invest
, vol.109
, pp. 1125-1131
-
-
Horton, J.D.1
Goldstein, J.L.2
Brown, M.S.3
-
34
-
-
79960555502
-
Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo
-
Wang S, Kamat A, Pergola P, Swamy A, Tio F, Cusi K. Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo. Metabolism 2011;60:1090-9.
-
(2011)
Metabolism
, vol.60
, pp. 1090-1099
-
-
Wang, S.1
Kamat, A.2
Pergola, P.3
Swamy, A.4
Tio, F.5
Cusi, K.6
-
35
-
-
33644652183
-
Sorting out the roles of PPARα in energy metabolism and vascular homeostasis
-
Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPARα in energy metabolism and vascular homeostasis. J Clin Invest 2006;116:571-80.
-
(2006)
J Clin Invest
, vol.116
, pp. 571-580
-
-
Lefebvre, P.1
Chinetti, G.2
Fruchart, J.C.3
Staels, B.4
-
36
-
-
39849099238
-
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
-
Kallwitz E, McLachlan A, Cotler S. Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease. World J Gastroenterol 2008;14:22-8.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 22-28
-
-
Kallwitz, E.1
McLachlan, A.2
Cotler, S.3
-
37
-
-
29044433513
-
Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes
-
Huang TH, Yang Q, Harada M, Uberai J, Radford J, Li GQ et al. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes. Toxicol Appl Pharmacol 2006;210:78-85.
-
(2006)
Toxicol Appl Pharmacol
, vol.210
, pp. 78-85
-
-
Huang, T.H.1
Yang, Q.2
Harada, M.3
Uberai, J.4
Radford, J.5
Li, G.Q.6
-
38
-
-
1542283630
-
Peroxisome proliferator receptor alpha target genes
-
Mandard S, Müller M, Kersten S. Peroxisome proliferator receptor alpha target genes. Cell Mol Life Sci 2004;61:393-416.
-
(2004)
Cell Mol Life Sci
, vol.61
, pp. 393-416
-
-
Mandard, S.1
Müller, M.2
Kersten, S.3
|